We are live on ! Find out more

269 hedge funds and large institutions have $2.24B invested in RXO in 2025 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 76 increasing their positions, 102 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

19% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 43

1% more funds holding

Funds holding: 266269 (+3)

0.65% less ownership

Funds ownership: 108.38%107.73% (-0.65%)

8% less call options, than puts

Call options by funds: $4.41M | Put options by funds: $4.8M

18% less capital invested

Capital invested by funds: $2.73B → $2.24B (-$499M)

25% less repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 102

Holders
269
Holders Change
+3
Holders Change %
+1.13%
% of All Funds
3.25%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
51
Increased
76
Reduced
102
Closed
43
Calls
$4.41M
Puts
$4.8M
Net Calls
-$391K
Net Calls Change
+$13.6M

RXO Hedge Fund Activity: Q4 2025 in Review

269 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in RXO (RXO) for Q4 2025, worth a combined $2.24B — down 18% from $2.73B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new RXO positions and 43 closed out — a net gain of 8 holders — while 76 added to existing stakes and 102 trimmed.

The largest buyer was Finepoint Capital, adding an estimated $31.3M. The largest seller was Wellington Management Group, cutting an estimated $78M.

  • 269 institutional investors held RXO (RXO) as of Q4 2025, up from 266 in Q3 2025.
  • Funds reported $2.24B of RXO stock for Q4 2025, down 18% quarter-over-quarter.
  • 51 funds opened new RXO positions in Q4 2025 and 43 closed out, a net change of +8 holders.
  • The largest RXO buyer in Q4 2025 was Finepoint Capital, an estimated $31.3M added.
  • The largest RXO seller in Q4 2025 was Wellington Management Group, an estimated $78M sold.

Based on aggregated 13F filings for Q4 2025.